THERAPEUTIC HUMAN POLYCLONALS
THP is an emerging biotechnology company focused on research in the field of human antibody technologies. THP has developed a unique transgenic mammalian platform to create human antibodies. The technology will enable the generation of both monoclonal and polyclonal antibody therapeutics with enhanced efficacy.
Similar Organizations
PH Precision Med
PHPM is a privately-held clinical stage biotech company focused on developing imatinib for the treatment of pulmonary arterial hypertension.
More informations about "Therapeutic Human Polyclonals"
Therapeutic Human Polyclonals, Inc. | Research Corporation ...
Therapeutic Human Polyclonals, Inc. Therapeutic Human Polyclonals, Inc., (THP) was founded as a biotherapeutics company to develop a unique transgenic mammalian platform to create …See details»
Therapeutic Human Polyclonals - PitchBook
Jan 1, 2000 Therapeutic Human Polyclonals General Information Description. Developer of transgenic mammalian platform to create human antibodies. The company's technology …See details»
Therapeutic Human Polyclonals - 2025 Company Profile - Tracxn
Mar 23, 2025 Therapeutic Human Polyclonals - Transgenic mammalian platform for generating antibodies. Acquired by Roche. Raised a total funding of $5M over 3 rounds from 1 investor. …See details»
Therapeutic Human Polyclonals Inc. - VentureRadar
Therapeutic Human Polyclonals Inc. VentureRadar profile. Find out more about Therapeutic Human Polyclonals Inc. including the VentureRadar Innovation and Growth scores, Similar …See details»
Roche acquires Therapeutic Human Polyclonals - Crunchbase
Apr 2, 2007 Therapeutic Human Polyclonals THP is an emerging biotechnology company focused on research in the field of human antibody technologies. Acquiring Organization: …See details»
Therapeutic Human Polyclonals, Inc. - Drug pipelines, Patents, …
Last update 01 Nov 2024. Therapeutic Human Polyclonals, Inc. Subsidiary Company |See details»
Therapeutic Human Polyclonals - Products, Competitors, Financials ...
Therapeutic Human Polyclonals (THP) is an emerging biotechnology company focused on research in the field of human antibody technologies. Use the CB Insights Platform to explore …See details»
Roche buys Therapeutic Human Polyclonals for $56.5 million
Apr 2, 2007 Just days after agreeing to acquire 454 Life Sciences, a subsidiary of CuraGen Corp which focuses on high-throughput DNA sequencing for $154.9 million, Switzerland’s Roche …See details»
Roche Acquires THP in $56.5 Million Deal - Business Wire
Apr 2, 2007 Therapeutic Human Polyclonals Inc. Wim Van Schooten, CEO, 650-387-8155 Contacts Therapeutic Human Polyclonals Inc. Wim Van Schooten, CEO, 650-387-8155See details»
Roche snaps up antibody tech company for $56.5M
Apr 1, 2007 Looking for a more efficient way to produce antibodies, Roche has agreed to buy Therapeutic Human Polyclonals, a U.S.-German company, for $56.5 million. The company has …See details»
Therapeutic Human Polyclonals Inc. - VentureRadar
OncoResponse USA Privately Held OncoResponse discovers and develops highly targeted and immuno-oncology therapeutic antibodies against novel cancer targets. The OncoResponse …See details»
Therapeutic Human Polyclonals, Inc.:Company Profile & Technical ...
Therapeutic Human is a company that provides Antibody, Medicine, Biotechnology and more. Therapeutic Human is headquartered in US CA. Therapeutic Human was founded in 1987. …See details»
Therapeutic Human Polyclonals Inc - Company Profile and News
Company profile page for Therapeutic Human Polyclonals Inc including stock price, company news, executives, board members, and contact informationSee details»
Therapeutic Human Polyclonals - Crunchbase
THP is an emerging biotechnology company focused on research in the field of human antibody technologies. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. …See details»
Roche Delves Into Therapeutic Antibodies and Vaccines
Apr 22, 2007 Roche (Basel, Switzerland, www.roche.com) has acquired Therapeutic Human Polyclonals, Inc. (THP, Mountain View, CA, www.polyclonals.com), a privately-owned …See details»
Building Monoclonal Antibody Production - pharmtech.com
Jun 2, 2007 In April, Roche (Basel, Switzerland) bought Therapeutic Human Polyclonals (THP, Mountain View, CA) for $56.5 million. THP has a transgenic mammalian platform (using …See details»
Roche Acquires Therapeutic Human Polyclonals For $56.5M
Apr 3, 2007 F. Hoffman-La Roche Ltd. continued its recent flurry of deal making by shelling out $56.5 million in cash for Therapeutic Human Polyclonals Inc. (THP) and its antibody-producing …See details»
Therapeutic Human Polyclonals GmbH, Bernried - North Data
Geschäftsführer (3 Personen) · Nicht mehr Geschäftsführer (2 Personen) · Firmensitz: Bernried · Name: Therapeutic Human Polyclonals GmbH · Satzung · Unternehmensgegenstand 24.09.2002See details»
Tumor-Infiltrating Clonal Hematopoiesis | New England Journal of …
4 days ago The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia 2022;36:1703-1719.See details»